Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Zurich Stories

2013-09-24 00:20:50

ZURICH, Switzerland, September 24, 2013 /PRNewswire/ -- Leading Swiss telecom operator upc cablecom will roll-out its new Carrier Ethernet 2.0 service deploying Albis Technologies Ethernet Demarcation Devices. Albis' ACCEED devices will enable upc cablecom to fulfil the demand of enterprise customers for Ethernet connectivity meeting highest quality standards. The ACCEED 2000 series fiber demarcation devices will be connected to the high performance packet backbone...

2013-09-19 00:21:22

LONDON AND ZURICH, Sept. 18, 2013 /CNW/ - On September 16, 2013, Catlin Underwriting Agencies Limited for and on behalf of Syndicate 2003 ("CUAL") and Catlin Re Switzerland Ltd. ("CRCH") entered into an agreement with Input Capital Corporation ("Input"), pursuant to which CUAL agreed to acquire 7,913,636 Class A common voting shares of Input and CRCH agreed to acquire 2,967,614 Class A common voting shares of Input on a private placement basis at a price of C$1.60 per Class A common...

2013-09-12 08:34:47

Oclaro also receives $5 million for option to sell amplifier and micro-optics business for $88 million SAN JOSE, Calif., Sept. 12, 2013 /PRNewswire/ -- Oclaro, Inc. (NASDAQ: OCLR), a leading provider and innovator of optical communications solutions, today announced that it has sold its Oclaro Switzerland GmbH subsidiary and associated laser diodes business to II-VI Incorporated (NASDAQ:IIVI) in a transaction valued at $115 million. In addition, II-VI acquired an exclusive option to...

2013-09-09 00:21:15

Patients with baseline blood eosinophil counts above 0.1 cells/nL respond to treatment with CYT003 ZURICH, September 9, 2013 /PRNewswire/ -- Cytos Biotechnology Ltd (SIX:CYTN) today announced additional results of the phase 2a clinical trial with CYT003, a first-in-class immune modulator in clinical development as a potential new treatment for allergic asthma. A post-hoc analysis of data published in the March issue of The Journal of Allergy and Clinical Immunology [1] are...

2013-08-28 08:30:00

ZURICH, Aug. 28, 2013 /PRNewswire/ -- KPMG partners with Appway, the global leader in client onboarding solutions, to enhance its Country Manuals - one of the key services KPMG provides its banking clients as part of its cross-border service. Due to increasing regulatory demand for transparency, many banks are being forced to adjust their business models and seek expert specialist advice in order to remain compliant. KPMG, who has a presence in over 140 countries, has developed a...

2013-08-27 12:24:32

ZURICH, August 27, 2013 /PRNewswire/ -- It is the second time that the Basel Declaration grants its "Award for Education in Animal Research". Chiara Ruzza, PhD in pharmacology and molecular oncology, is currently completing a post-doctorate at the University of Ferrara, Italy. The prize winner takes part in a one-week course on Animal research at the University of Zurich, based on the rules of the 3Rs (Replace, Reduce, Refine). She has been mandated by her university to set up...

2013-08-22 08:27:40

ZURICH, August 22, 2013 /PRNewswire/ -- Demonstrates Takeda's long-term commitment to the Latin American market Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion of its presence in Latin America with the launch of a wholly-owned subsidiary in Peru. Takeda Peru S.R.L. (Takeda Peru or "the Company") will be headquartered in Lima and will be responsible for the sales and marketing of Takeda's products in Peru. Takeda is building...

2013-08-15 00:20:33

Huge Lasershows have been performed on 3 stages at Street Parade 2013 in Zurich by Laserworld. 950,000 people came to celebrate the gigantic party in the city center of Zurich, titled 'Dance for Freedom' ZURICH, Aug. 14, 2013 /PRNewswire/ -- On Saturday, August 10(th) a giant movement of people cascaded through downtown Zurich with almost 1 million fans joining the 22(nd) Street Parade celebrating from 1pm to midnight right next to the famous Lake Zurich. It seems that there have...

2013-08-14 04:20:39

ZURICH, August 14, 2013 /PRNewswire/ -- Problem: Chronic Pain One out of five adults suffers from chronic pain and half of all patients have been suffering for at least seven years (median). Patients usually go through an odyssey of examinations and treatments while long term relief becomes a hope rather than an expectation. The new pain diary app CatchMyPain [http://www.catchmypain.com ] promises to put an end to this odyssey. Solution: Learning from each other...

2013-08-06 00:21:42

ZURICH, August 6, 2013 /PRNewswire/ -- - Global Phase 2b clinical trial with CYT003 progressing as planned - Development team for CYT003 strengthened - A*Star and Cytos bring Singapore's first influenza vaccine to clinical testing - All agenda items approved at the Annual Shareholders' Meeting Cytos Biotechnology Ltd. ("Cytos" or the "Company") announced today its financial results and business highlights for the quarter ended June...